1. Home
  2. RPD vs AMPH Comparison

RPD vs AMPH Comparison

Compare RPD & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPD
  • AMPH
  • Stock Information
  • Founded
  • RPD 2000
  • AMPH 1996
  • Country
  • RPD United States
  • AMPH United States
  • Employees
  • RPD N/A
  • AMPH N/A
  • Industry
  • RPD Computer Software: Prepackaged Software
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • RPD Technology
  • AMPH Health Care
  • Exchange
  • RPD Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • RPD 2.1B
  • AMPH 2.5B
  • IPO Year
  • RPD 2015
  • AMPH 2014
  • Fundamental
  • Price
  • RPD $41.31
  • AMPH $39.97
  • Analyst Decision
  • RPD Buy
  • AMPH Buy
  • Analyst Count
  • RPD 17
  • AMPH 4
  • Target Price
  • RPD $45.25
  • AMPH $60.33
  • AVG Volume (30 Days)
  • RPD 756.5K
  • AMPH 458.4K
  • Earning Date
  • RPD 02-05-2025
  • AMPH 11-06-2024
  • Dividend Yield
  • RPD N/A
  • AMPH N/A
  • EPS Growth
  • RPD N/A
  • AMPH 17.38
  • EPS
  • RPD 0.66
  • AMPH 3.01
  • Revenue
  • RPD $833,014,000.00
  • AMPH $723,549,000.00
  • Revenue This Year
  • RPD $9.10
  • AMPH $16.86
  • Revenue Next Year
  • RPD $5.46
  • AMPH $10.07
  • P/E Ratio
  • RPD $59.15
  • AMPH $13.58
  • Revenue Growth
  • RPD 10.05
  • AMPH 20.33
  • 52 Week Low
  • RPD $32.95
  • AMPH $36.56
  • 52 Week High
  • RPD $61.88
  • AMPH $65.92
  • Technical
  • Relative Strength Index (RSI)
  • RPD 45.14
  • AMPH 30.85
  • Support Level
  • RPD $38.54
  • AMPH $40.37
  • Resistance Level
  • RPD $44.47
  • AMPH $45.39
  • Average True Range (ATR)
  • RPD 1.08
  • AMPH 1.24
  • MACD
  • RPD -0.45
  • AMPH -0.25
  • Stochastic Oscillator
  • RPD 29.57
  • AMPH 7.06

About RPD Rapid7 Inc.

Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: